Showing results (41-50 of 324) with videos related to
Sort By:
Pageof 33
Hematology/Oncology Clinics of North America|April 30, 2019
Thrombosis in Children: Approach to Anatomic Risks, Thrombophilia, Prevention, and TreatmentArash Mahajerin, Marisol Betensky, Neil A GoldenbergPediatric Clinics of North America|November 19, 2013
Antithrombotic therapies: anticoagulation and thrombolysisRuchika Goel, Suresh Vedantham, Neil A GoldenbergSeminars in Thrombosis and Hemostasis|December 18, 2024
Recurrent Thromboembolism in Pediatric Congenital Heart Disease: Cumulative Incidence and Prognostic FactorsAmy L Kiskaddon, Therese M Giglia, Marisol Betensky, et al.Proteomics. Clinical Applications|September 16, 2014
The utility of dried blood spots for proteomic studies: looking forward to looking backVera Ignjatovic, James Pitt, Paul Monagle, et al.Thrombosis Research|April 4, 2008
The in vitro anticoagulant effects of danaparoid, fondaparinux, and lepirudin in children compared to adultsVera Ignjatovic, Robyn Summerhayes, Yan Yan Yip, et al.Thrombosis Research|February 24, 2018
Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized childrenBrian R Branchford, Marisol Betensky, Neil A GoldenbergBlood|February 3, 2025
How I approach pharmacological thromboprophylaxis in childrenAnthony A Sochet, Amy Kiskaddon, Neil A GoldenbergJournal of Pediatric Hematology/Oncology|October 19, 2013
Long-term follow-up of homozygote protein C deficiency after multimodal therapyKate Monagle, Vera Ignjatovic, Winita Hardikar, et al.Pediatric Hematology and Oncology|June 2, 2017
Characterization of the coagulation profile in children with liver disease and extrahepatic portal vein obstruction or shuntWilliam Beattie, Maria Magnusson, Winita Hardikar, et al.British Journal of Haematology|March 30, 2010
Dosing and monitoring of enoxaparin (Low molecular weight heparin) therapy in childrenVera Ignjatovic, Siti Najid, Fiona Newall, et al.Pageof 33